Sains Malaysiana 46(10)(2017): 1903–1911
http://dx.doi.org/10.17576/jsm-2017-4610-29
Treatment with Pueraria mirificaExtract Prevented Muscle Atrophy and
Restored Muscle Strength in Ovariectomized Rats
(Rawatan dengan Ekstrak Pueraria mirificabagi Menghalang Atrofi dan Memulihkan Kekuatan Otot Tikus Diovariektomi)
KOCHAKORN SUKJAN INTHANUCHIT1, WANDEE UDOMUKSORN2, EKKASIT KUMARNSIT3, SURAPONG VONGVATCHARANON4 & URAPORN VONGVATCHARANON5*
1Faculty
of Traditional Thai Medicine, Prince of Songkla University, Songkhla, 90110, Thailand
2Department
of Pharmacology, Faculty of Science, Prince of Songkla University, Songkhla, 90110, Thailand
3Department
of Physiology, Faculty of Science, Prince of Songkla University, Songkhla, 90110, Thailand
4Department
of Oral Surgery (Anesthesiology section), Faculty of Dentistry, Prince of Songkla University, Songkhla,
90110, Thailand
5Department of Anatomy, Faculty of
Science, Prince of Songkla University, Songkhla, 90110, Thailand
Diserahkan: 5 Mei 2016/Diterima: 28 Mac 2017
ABSTRACT
Pueraria mirifica (PM)
is a phytoestrogen-rich plant that was tested to establish if its phytosteroids could prevent estrogen dependent sarcopenia.
The effect of PM on the estrogen levels, estrous cycle, toxicity,
muscle mass, strength and endurance of extensor digitorum longus (EDL) and gastrocnemius muscles of ovariectomized rats was investigated. Adult female Wistar rats were
divided into six groups: Sham-operated (SHAM); ovariectomized (OVX)
fed with distilled water (PM0); OVX injected
with 40 μg/kg estradiol benzoate (E40); (4-6) OVX fed
with ethanolic extract of PM at
doses of 50 (PM50), 500 (PM500) and 1000 (PM1000)
mg/kg for 90 days. After treatment with all three doses of PM,
no toxicity was detected to the hematopoietic system and liver function whereas
the E40 group did show toxic effects. Treatment with 50 and 500 mg/kg of PM showed
no effect on uterine hypertrophy and caused no arrest of the estrous cycle
whereas treatment with estrogen and 1000 mg/kg of PM treatment
did. The estrogen level, the cross sectional area of the EDL and
the gastrocnemius muscle fiber strength and endurance were all significantly
reduced in the PM0 group compared to that of the SHAM group (p<0.05) but were significantly increased in the
E40, PM50, PM500 and PM1000
compared to that of the PM0 group (p<0.05). This
indicated that the estrogenic activity of PM alleviated
muscle atrophy and built up muscle strength and endurance. Thus, the 50 and 500
mg/kg of PM were suitable for treating estrogen dependent
sarcopenia in ovariectomized rats.
Keywords: Estrogen; ovariectomy; Pueraria mirifica;
sarcopenia
ABSTRAK
Pueraria mirifica (PM) adalah tumbuhan kaya fitoestrogen yang diuji untuk menentukan jika fitosteroidnya boleh menghalang sarkopenia terbergantung estrogen. Kesan PM pada tahap estrogen, kitaran estrous, ketoksikan, jisim otot, kekuatan dan ketahanan ekstensor digitorum longus
(EDL) dan otot gastrocnemius tikus diovariektomi telah dikaji. Tikus Wistar betina dewasa dibahagikan kepada enam kumpulan:
sham-dikawal (SHAM), ovariektomi (OVX) diberi air suling (PM0), OVX disuntik dengan 40 μg/kg estradiol benzoat (E40), OVX diberi ekstrak etanol PM pada dos 50 (PM50), 500 (PM500) dan 1000 (PM1000) mg/kg selama 90 hari. Selepas rawatan dengan ketiga-tiga dos PM, tiada ketoksikan dikesan pada sistem hematopoietik dan fungsi hati manakala kumpulan E40 menunjukkan kesan toksik. Rawatan dengan 50 dan 500 mg/kg PM tidak memberi kesan pada hipertrofi rahim dan tidak menyebabkan gangguan pada kitaran estrous berbanding rawatan dengan estrogen dan 1000 mg/kg rawatan PM yang menunjukkan kesan. Tahap estrogen, luas keratan rentas EDL dan kekuatan serta ketahanan gentian otot gastrocnemius berkurang secara signifikan dalam kumpulan PM0 berbanding dengan kumpulan SHAM (p<0.05) yang meningkat dengan ketara dalam E40, PM50, PM500 dan PM1000 berbanding dengan kumpulan PM0
(p<0.05). Ini menunjukkan bahawa aktiviti estrogenik PM mengurangkan atrofi otot dan membina kekuatan dan ketahanan otot. Oleh itu, 50 dan 500 mg/kg PM adalah sesuai untuk merawat sarcopenia bergantung estrogen kepada tikus diovariektomi.
Kata kunci: Estrogen; ovariektomi; Pueraria mirifica; sarkopenia
RUJUKAN
Amin, I.M., Kamaludin, R., Yeap, S.K., Isa, M.R., Rosda,
N.M.M.N.M., Siran, R., Kadir,
S.H.S.A & Hasani, N.A.H.H. 2015. Aloe emodin induces apoptosis in ER+-breast
cancer cells; MCF-7 through IGF-IR signalling pathway. Sains Malaysiana 44(8): 1137-1143.
Boonchird, C., Mahapanichkul, T. & Cherdshewasart, W. 2010. Differential binding
with ERalpha and ERbeta of
the phytoestrogen-rich plant Pueraria mirifica. Brazilian Journal of Medical and
Biological Research 43(2): 195-200.
Bunratsami, S., Udomuksorn, W., Kumarnsit, E., Vongvatcharanon,
S. & Vongvatcharanon, U. 2015. Estrogen replacement improves skeletal muscle performance by
increasing parvalbumin levels in ovariectomized rats. Acta Histochemica 117(2): 163-175.
Chansakaow,
S., Ishikawa, T., Seki, H., Sekine, K., Okada, M.
& Chaichantipyuth, C. 2000. Identification of deoxymiroestrol as the
actual rejuvenating principle of “Kwao Keur”, Pueraria mirifica. The known miroestrol may be an artifact. Journal of Natural Products 63(2): 173-175.
Cherdshewasart,
W. 2003. Toxicity tests of a
phytoestrogen-rich herb; Pueraria mirifica. Journal of Scientific Research Chulalongkorn University 28(12): 1-13.
Cherdshewasart,
W., Sutjit, W., Pulcharoen,
K. & Chulasiri, M. 2009. The mutagenic and antimutagenic effects
of the traditional phytoestrogen-rich herbs, Pueraria mirificaand Pueraria lobata. Brazilian Journal of Medical
and Biological Research 42(9): 816-823.
Cherdshewasart,
W., Panriansaen, R. & Picha,
P. 2007a. Pretreatment with phytoestrogen-rich plant
decreases breast tumor incidence and exhibits lower profile of mammary ER-alpha
and ER-beta. Maturitas 58(2): 174-181.
Cherdshewasart,
W., Subtang, S. & Dahlan,
W. 2007b. Major isoflavonoid contents of the phytoestrogen rich-herb Pueraria mirificain comparison with Pueraria lobata. Journal of Pharmaceutical and
Biomedical Analysis 43(2): 428-434.
Hall,
J.M. 2001. The multifaceted mechanisms of
estradiol and estrogen receptor signaling. Journal of Biological
Chemistry 276: 36869-36872.
Lang,
T., Streeper, T., Cawthon, P., Baldwin, K., Taaffe,
D.R. & Harris, T.B. 2010. Sarcopenia: Etiology, clinical
consequences, intervention, and assessment. Osteoporosis International 21(4):
543-559.
Malaivijitnond,
S., Tungmunnithum, D., Gittarasanee,
S., Kawin, K. & Limjunyawong, N. 2010. Puerarin exhibits weak estrogenic activity in female rats. Fitoterapia 81(6): 569-576.
Malaivijitnond,
S., Kiatthaipipat, P., Cherdshewasart,
W., Watanabe, G. & Taya, K. 2004. Different
effects of Pueraria mirifica, a herb containing phytoestrogens, on LH and FSH
secretion in gonadectomized female and male rats. Journal
of Pharmacological Sciences 96(4): 428-435.
Manosroi,
A., Saowakon, S. & Manosroi,
J. 2004. Preliminary chronic toxicity
study of herbal formulations containing Red Kwao Krua (Butea superbaRoxb.) or White Kwao Krua (Pueraria mirificaAiry Shaw and Suvatabandhu)
in Wistar rats. Thai Pharmaceutical and
Health Science Journal 9(1): 1-12.
Marsden,
J. 2002. Hormone-replacement therapy and breast cancer. The Lancet Oncology 3(5): 303-311.
Messier,
V., Rabasa-Lhoret, R., Barbat-Artigas,
S., Elisha, B., Karelis, A.D. & Aubertin-Leheudre,
M. 2011. Menopause and sarcopenia: A potential role for sex
hormones. Maturitas 68(4): 331-336.
Moran,
A.L., Nelson, S.A., Landisch, R.M., Warren, G.L.
& Lowe, D.A. 2007. Estradiol replacement reverses ovariectomy-induced
muscle contractile and myosin dysfunction in mature female mice. Journal of
Applied Physiology 102(4): 1387-1393.
Moran,
A.L., Warren, G.L. & Lowe, D.A. 2006. Removal of
ovarian hormones from mature mice detrimentally affects muscle contractile
function and myosin structural distribution. Journal of Applied Physiology 100(2):
548-559.
Norshafarina,
S.K., Ibrahim, M.S.N., Suzana, S., Hasnan, A.M., Zahara, M. & Zaitun, Y. 2013. Sarcopenia and its impact on health: Do
they have significant association?. Sains Malaysiana42(9):
1345-1355.
Park,
H.J., Della-Fera, M.A., Hausman,
D.B., Rayalam, S., Ambati, S. & Baile, C.A. 2009. Genistein inhibits differentiation of primary human
adipocytes. The Journal of Nutritional Biochemistry 20(2): 140-148.
Pope,
G.S., Grundy, H.M., Jone, H.E.M. & Tait, S.A.S.
1958. The estrogenic substance (miroestrol)
from the tuberous roots of Pueraria mirifica. Journal of Endocrinology 17:
15-16.
Sipila, S.,
Taaffe, D.R., Cheng, S., Puolakka, J., Toivanen, J. & Suominen, H.
2001. Effects of hormone replacement therapy and high-impact physical exercise
on skeletal muscle in post-menopausal women: A randomized placebo-controlled
study. Clinical Science 101(2): 147-157.
Suntara,
A. 1931. The Remedy Pamphlet of Kwao Krua Tuber of Luang Anusarnsuntarakromkarnphiset. Chiang Mai, Thailand: Chiang Mai Upatipongsa Press.
Taylor,
N.E., Hodgkin, D.C. & Rollett, J.S. 1960. The X-ray crystallographic determination of the structure of bromomiroestrol. Journal of the Chemical Society 73 : 3685-3695.
Trisomboon, H., Malaivijitnond, S., Cherdshewasart,
W., Watanabe, G. & Taya, K. 2006. Effect of Pueraria mirificaon
the sexual skin coloration of aged menopausal cynomolgus monkeys. Journal of Reproduction and Development 52(4): 537-542.
Urasopon,
N., Hamada, Y., Cherdshewasart, W. & Malaivijitnond, S. 2008. Preventive effects of Pueraria mirificaon bone loss in ovariectomized rats. Maturitas 59(2): 137-148.
Wirakiat,
W., Udomuksorn, W., Vongvatcharanon,
S. & Vongvatcharanon, U. 2012. Effects of estrogen via estrogen receptors on parvalbumin levels in cardiac myocytes of ovariectomized rats. Acta Histochemica 114(1): 46-54.
*Pengarang untuk surat-menyurat; email: uraporn.v@psu.ac.th